Breast stem cell cryopreservation liquid, preparation method and cryopreservation method thereof
A technology of mammary gland stem cells and cryopreservation method, which is applied to the preservation, application, and animal husbandry of human or animal bodies, and can solve the problems of mammary gland stem cell damage, poor cryopreservation effect, and loss of function, so as to avoid toxic effects and maintain Multidirectional differentiation and self-renewal ability, and the effect of maintaining stemness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] A breast stem cell lysery, and the freeze-containing mix is mixed by a liquid and B liquid:
[0036] The volume ratio of the A liquid to the B liquid is 1: 1;
[0037] The A liquid is 100 parts by volume, including the following volume of components: 25 parts of glycerin and 75 calf serum;
[0038] The B liquid is 100 parts per scale, including the following components: 75 DMEM / F12 basic medium, 20 calf serum, 2 parts without vitamin A type B-27 (50x), 2.5 parts of heparin (2μg / ML), 0.4 parts of insulin (10 μg / mL), 0.04 recombinant basic fibroblast growth factor (10 ng / ml), 0.05 parts of epithelial cell growth factor (4 ng / ml) and 0.01 y-27632 (100 mM).
Embodiment 2
[0040] The preferred embodiment of the preferred embodiment of the present invention is provided with a mammary stem cell lysery, and the freeze-containing mix is mixed by a liquid and a B liquid:
[0041] The volume ratio of a liquid and B liquid is 2: 1;
[0042] The A fluid is 100 parts per meter, including the following volume: 40 parts of glycerol and 60 calf serum;
[0043] The B liquid is 100 parts per scale, including the following components: 75 DMEM / F12 basic medium, 20 calf serum, 2 parts without vitamin A type B-27 (50x), 2.5 parts of heparin (2μg / ML), 0.4 parts of insulin (10 μg / mL), 0.04 recombinant basic fibroblast growth factor (10 ng / ml), 0.05 parts of epithelial cell growth factor (4 ng / ml) and 0.01 y-27632 (100 mM).
Embodiment 3
[0045] The preferred embodiment of the preferred embodiment of the present invention is provided with a mammary stem cell lysery, and the freeze-containing mix is mixed by a liquid and a B liquid:
[0046] The volume ratio of a liquid and B liquid is 2: 1;
[0047] The A liquid is 100 parts by volume, including the following volume of components: 20 parts of glycerin and 80 calf serum;
[0048]The B liquid is 100 parts per scale, including the following components: 75 DMEM / F12 basic medium, 20 calf serum, 2 parts without vitamin A type B-27 (50x), 2.5 parts of heparin (2μg / ML), 0.4 parts of insulin (10 μg / mL), 0.04 recombinant basic fibroblast growth factor (10 ng / ml), 0.05 parts of epithelial cell growth factor (4 ng / ml) and 0.01 y-27632 (100 mM).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


